Pharming Group N.V annual free cash flow
2019
2020
2021
2022
2023
2024
2025
Pharming Group N.V Free Cash Flow (FCF) History (PHAR)
Pharming Group N.V reported $54.0M in free cash flow for fiscal 2025, an increase of $56.5M from the previous fiscal year, with a free cash flow margin of 14.35%.
View full Pharming Group N.V company overviewPharming Group N.V free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | $54.0M | $56.5M | — | +14.35% |
| 2024 | 2024-12-31 | −$2.6M | $16.2M | — | −0.87% |
| 2023 | 2023-12-31 | −$18.7M | −$39.8M | — | −7.64% |
| 2022 | 2022-12-31 | $21.1M | −$6.0M | −22.22% | +10.25% |
| 2021 | 2021-12-31 | $27.1M | −$51.9M | −65.68% | +13.63% |
| 2020 | 2020-12-31 | $79.0M | $7.5M | +10.44% | +37.22% |
| 2019 | 2019-12-31 | $71.5M | — | — | +37.75% |
Pharming Group N.V quarterly free cash flow
No reported data
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|
Pharming Group N.V free cash flow growth trends
Over the last five reported fiscal years, free cash flow declined from $79.0M to $54.0M, a compound annual decline of 7.33%.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Pharming Group N.V filings at SEC.gov ↗